EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications

Kai Xu, Zainab Motiwala iD, Irene Corona-Avila, Dhruvi Makhanasa, Leen Alkahalifeh, Md Wasim Khan iD

Technology in Cancer Research & Treatment · 2025-06 · 24

DOI: 10.1177/15330338251331960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 10.04.2025. Verfasst von Kai Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DOD Peer Reviewed Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review summarizes the intricate relationship between the microbiome and cancer initiation and development. Microbiome alterations impact metabolic pathways, immune responses, and gene expression, which can accelerate or mitigate cancer progression. We examine how dysbiosis affects tumor growth, metastasis, and treatment resistance. Additionally, we discuss the potential of microbiome-targeted therapies, such as probiotics and fecal microbiota transplants, to modulate cancer metabolism. These interventions offer the possibility of reversing or controlling cancer progression, enhancing the efficacy of traditional treatments like chemotherapy and immunotherapy. Despite promising developments, challenges remain in identifying key microbial species and pathways and validating microbiome-targeted therapies through large-scale clinical trials. Nonetheless, the intersection of microbiome research and cancer initiation and development presents an exciting frontier for innovative therapies. This review offers a fresh perspective on cancer initiation and development by integrating microbiome insights, highlighting the potential for interdisciplinary research to enhance our understanding of cancer progression and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNeoplasmsHumansDisease ProgressionAnimalsDysbiosisProbioticsFecal Microbiota Transplantation

Stichwörter der Autor:innen

biomarkercancergut microbiomemechanismtherapy

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA.
  • Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India.
  • Al Mouwassat University Hospital, Damascus, Syria.

ORCID-Profile: Zainab Motiwala, Md Wasim Khan

Förderung

  • DOD Peer Reviewed Cancer Research Program

Zitieren

APA

Xu, K., Motiwala, Z., Corona-Avila, I., Makhanasa, D., Alkahalifeh, L., & Khan, M. W. (2025). The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications. Technology in Cancer Research & Treatment, 24. https://doi.org/10.1177/15330338251331960

Vancouver

Xu K, Motiwala Z, Corona-Avila I, Makhanasa D, Alkahalifeh L, Khan MW. The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications. Technology in Cancer Research & Treatment. 2025;24. doi:10.1177/15330338251331960

BibTeX
@article{Xu2025,
  author = {Xu, Kai and Motiwala, Zainab and Corona-Avila, Irene and Makhanasa, Dhruvi and Alkahalifeh, Leen and Khan, Md Wasim},
  title = {The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  volume = {24},
  doi = {10.1177/15330338251331960}
}
Kostenlos starten →